Literature DB >> 6965804

Bone scanning in the child and young adult. Part I.

I P Murray.   

Abstract

Radionuclide bone scanning will identify readily areas of the skeleton where vascularity or osteogenesis is disturbed. Frequently, this will be achieved with a greater sensitivity than orthodox radiology by reflecting altered local physiology of bone. This procedure is, therefore, valuable not only for identifying metastatic disease, but also in benign skeletal disorders characterised by altered blood flow or osteoblastic reaction. These changes occur in many diseases involving bone which are more common in children and young adults. Special attention to the performance of the study and to its interpretation is, however, required in these age groups. The bone scan is invaluable in detecting metastatic disease related to either primary bone tumours or other neoplasia, both in the initial investigation and in the evaluation of therapy. Extra-osseous uptake may also occur, providing useful information relevant to the care of these patients.

Entities:  

Mesh:

Year:  1980        PMID: 6965804     DOI: 10.1007/BF00347091

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  44 in total

1.  False negative bone scans in neuroblastoma metastatic to the ends of long bones.

Authors:  R A Kaufman; J H Thrall; J W Keyes; M L Brown; J F Zakem
Journal:  AJR Am J Roentgenol       Date:  1978-01       Impact factor: 3.959

2.  "Cold" bone lesions: a newly recognized phenomenon of bone imaging.

Authors:  T G Goergen; N P Alazraki; S E Halpern; V Heath; W L Ashburn
Journal:  J Nucl Med       Date:  1974-12       Impact factor: 10.057

3.  Radionuclide skeletal survey for pediatric neoplasms.

Authors:  D L Gilday; J M Ash; B J Reilly
Journal:  Radiology       Date:  1977-05       Impact factor: 11.105

4.  Bone scintigraphy in scurvy.

Authors:  D Front; R Hardoff; J Levy; A Benderly
Journal:  J Nucl Med       Date:  1978-08       Impact factor: 10.057

5.  Quantification of skeletal Tc-99m labeled phosphates to defect metabolic bone disease.

Authors:  R A Holmes
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

6.  Bone scanning in management of metastatic osteogenic sarcoma.

Authors:  A R Siddiqui; H N Wellman; R M Weetman; W L Smith
Journal:  Clin Nucl Med       Date:  1979-01       Impact factor: 7.794

7.  Rationale for the use of bone scans in selected metastatic and primary bone tumors.

Authors:  B J McNeil
Journal:  Semin Nucl Med       Date:  1978-10       Impact factor: 4.446

8.  The multiscan appearance of eosinophilic granuloma.

Authors:  S Antonmattei; M R Tetalman; T V Lloyd
Journal:  Clin Nucl Med       Date:  1979-02       Impact factor: 7.794

9.  The use of 99mc-EHDP as a scanning agent in the detection of metastases from osteosarcoma.

Authors:  S P Hughes; M K Benson; P J Ell; K E Britton
Journal:  Rofo       Date:  1977-06

10.  Bone scintigraphy of osteoid osteoma: a clinical review.

Authors:  H A Goldstein; S Treves
Journal:  Clin Nucl Med       Date:  1978-09       Impact factor: 7.794

View more
  2 in total

Review 1.  Radionuclide bone scanning.

Authors:  H Carty
Journal:  Arch Dis Child       Date:  1993-07       Impact factor: 3.791

2.  Iodine-125 labeled phenylphosphonic acid: a new radiopharmaceutical for long-term investigations of the skeleton.

Authors:  F P Castronovo; H W Strauss; K A McKusick; M S Potsaid
Journal:  Skeletal Radiol       Date:  1982-01       Impact factor: 2.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.